MarketScreener alternatives

MarketScreener is a news platform.Its screener is bolted on.

MarketScreener is built around analyst reports and news consensus — the screener is a secondary feature. At $30–34/month you are paying for a news subscription with filters, not a decision-oriented screening tool. These are the real screening alternatives.

Updated June 2026 · 5 alternatives reviewed

What a screening-first tool gives you over MarketScreener

Screening is the product

MarketScreener's core product is analyst consensus and news. ScreenerHero's core product is the screener — every design decision optimizes for filter-driven, multi-market screening.

Faster, denser UI

MarketScreener's interface is table-based but slow — it is optimized for reading reports, not scanning filter results. ScreenerHero applies filters instantly and returns dense sortable tables.

US + Canada included

MarketScreener's screener covers European and some global names. ScreenerHero covers US, Canada, and all of Europe in the same screener with the same filter set.

Lower effective price

MarketScreener is $30–34/month for a product that is primarily news. ScreenerHero is €29/month for a product that is entirely screening — with a free core tier that requires no account.

What to look for in a MarketScreener alternative

Screening as the core product

Does the tool exist to screen, or is the screener a feature added to a news or analyst-report platform?

Filter speed

MarketScreener is slow. Alternatives should apply filters in under a second and return a dense, sortable table.

Geographic breadth

Does it cover US, Canada, and European exchanges in the same screener — or does it focus on one region?

Analyst consensus vs raw data

MarketScreener's value is in analyst estimates and consensus. If you want raw fundamental filters rather than estimates, look elsewhere.

Price alignment

Are you paying for news, or for screening? Match the cost to the feature you actually use.

The 5 best MarketScreener alternatives (2026)

Top pick— ranked #1

ScreenerHero

Screening-first. US + Canada + all of Europe. Cheaper.

Free / €29/mo Pro

ScreenerHero is built around the screener — not news or analyst reports. Filter by fundamentals across US, Canadian, and all European equities including microcaps, in a dense table that updates instantly. Pro is €29/month — cheaper than MarketScreener, with broader coverage, a faster interface, and a free core screener that requires no account.

Markets

US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges

Screener filters

P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield

UI style

Desktop-first, data-dense, screening-first

Heatmap

Yes

Open ScreenerHero free
#2

Finviz

Benchmark dense screener for US equities — no meaningful European coverage

Free limited / $39.50/mo Elite

The reference standard for screening-first, dense UX. Finviz Elite is $39.50/month — more expensive than MarketScreener and ScreenerHero. US equities only. If you screen European names, Finviz cannot help. But for US-only workflows, it is the best-designed screener available.

Markets

US primarily

Screener filters

P/E, P/B, ROE, margins, momentum — US equities only

UI style

Desktop-first, data-dense, screener-first

Heatmap

Yes

#3

TradingView

World-class charts with a secondary screener

Free limited / $15–60/mo

Global coverage with excellent charting. The screener is secondary — fundamental depth for European small caps is inconsistent. A reasonable choice if charts drive your workflow more than systematic filtering does.

Markets

Global, including Europe

Screener filters

Technical-first; fundamental filters gated by plan

UI style

Chart-centric, screener is secondary

Heatmap

Yes

#4

Stockopedia

Score-driven research for European equities — expensive

€60/mo EU · €80/mo US+EU

StockRanks (quality, value, momentum) is well-regarded for UK equities. No Canadian equities. Continental European microcap coverage has gaps. At €60–80/month it is the most expensive option here for narrower coverage than ScreenerHero.

Markets

UK-weighted, some continental Europe (no Canada)

Screener filters

StockRanks composite (QVM) + custom filters

UI style

Card-based, research and editorial focus

Heatmap

No

#5

Simply Wall St

Visual stock stories — not a filter-driven screener

$10–22/mo

Good for understanding a single company visually. Not a screener in the systematic sense — you cannot filter by arbitrary fundamental criteria and get a dense sortable table. Useful for beginners exploring individual names.

Markets

Global, including Europe

Screener filters

Limited — snowflake visual, no dense filter combinations

UI style

Infographic cards, designed for individual stock browsing

Heatmap

No

Quick comparison

ScreenerHeroFinvizTradingViewStockopediaSimply Wall St
US coverage
Canadian coverage
European coverage
Microcap EU coverage
Screening-first UX
Dense table output
Heatmap
Free core features
No account required
Price/mo (from)€29$39.50$15€60$10
Legend:StrongPartialAbsent

Recommendation by use case

You want a screening-first tool for US, Canada, and European equities

ScreenerHero — €29/mo, screening-first, dense table output, free core screener.

You need analyst consensus and price targets alongside screening

MarketScreener — the deepest European analyst consensus database available; accept the news-first UX.

You screen US stocks only and want maximum density and speed

Finviz — the benchmark for dense US screening, at $39.50/month.

You need charts alongside your screening workflow

TradingView — world-class charting; accept the screener as secondary.

You prefer visual narratives over raw filter-driven screening

Simply Wall St — good for individual company exploration, not systematic multi-market screening.

A screener built for screening. Not news.

Filter by fundamentals across US, Canadian, and European equities — including microcaps. Dense tables. Instant results. Heatmap. Free, no account needed. Pro at €29/month.

MarketScreener Alternatives — Screening-First Tools for European Investors (2026) — ScreenerHero